(Q34343177)

1 August 2017

1 reference

title

Radiolabeled peptide ligands for imaging thrombi and emboli (English)

1 reference

1 August 2017

Knight LC

1

1 reference

1 August 2017

1 July 2001

1 reference

Nuclear Medicine and Biology

1 August 2017

1 reference

1 August 2017

28

1 reference

1 August 2017

5

1 reference

1 August 2017

515-526

1 reference

Cyclic RGD peptide analogues as antiplatelet antithrombotics

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

A new improved coil for tapered-tip catheter for arterial occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Platelets and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Disintegrins: a family of integrin inhibitory proteins from viper venoms

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Radiolabelled peptides--promises and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Viper venom disintegrins and related molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of αIIbβ3 and αvβ3 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Clinical pharmacology of eptifibatide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900222-0

7 January 2021

10.1016/S0969-8051(01)00222-0

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11516697